SK pharmteco Announces SKyvec™, A Unified, High-Yield Viral Vector Platform Designed to Accelerate Gene Therapy Development from Batch to Bedside

SK pharmteco today announced the launch of SKyvec™, its proprietary, multimodal viral vector platform. Designed to support ...